{"entity":{"id":"nct07419880","kind":"trial","name":"Re-challenge Immunotherapy With Cromolyn, TQB2102, and Panpulimab in Immune-Refractory Triple Negative Breast Cancer","aka":["RECLAIM"],"tldr":"A phase 2 trial of TQB2102 in triple-negative breast cancer, run by Fudan University, not yet recruiting.","summary":"Re-challenge Immunotherapy With Cromolyn, TQB2102, and Panpulimab in Immune-Refractory Triple Negative Breast Cancer is a phase 2, interventional study registered as NCT07419880 by Fudan University, with a registry enrolment figure of 46 participants, started 2026-01-30 and due to reach its primary completion in 2027-01-30. Interventions recorded: Cromolyn, TQB2102, and Panpulimab. Conditions listed: Triple -Negative Breast Cancer. Triple-negative eligibility wording from the registry: \"Diagnosis: Histologically confirmed invasive triple-negative breast cancer (defined as: ER-negative by IHC with \\<1% positive tumor cells; PR-negative with \\<1% positive tumor cells; HER2 0-1+ or HER2 2+ with confirmed negative FISH/CISH without amplification)\". Sites: China. No results are recorded here; the registry entry is the source.","status":"planned","asOf":"2026-09-24","links":[{"label":"ClinicalTrials.gov NCT07419880","url":"https://clinicaltrials.gov/study/NCT07419880"}],"tags":["ctgov-ingest","tnbc-deep-dive"],"related":[],"cancers":["tnbc-early"],"sections":[],"technologies":[],"targets":[],"drugs":["tqb2102"],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT07419880","phase":"2","setting":"RECLAIM: Re-challenge Immunotherapy With Cromolyn, TQB2102, and Panpulimab in Immune-Refractory Triple Negative Breast Cancer","sponsor":"Fudan University","enrolled":46,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct07419880/","neighbours":{"cancer":[{"id":"tnbc-early","kind":"cancer","name":"Early triple-negative breast cancer","route":"/cancers/tnbc-early/"}],"drug":[{"id":"tqb2102","kind":"drug","name":"TQB2102","route":"/drugs/tqb2102/"}],"term":[{"id":"tnbc-trials-open-today","kind":"term","name":"Triple-negative breast cancer trials open today (registry snapshot and UK sites)","route":"/terms/tnbc-trials-open-today/"}]}}